Child Health

1 نشط

1 النتائج

نشط
An open‐label extension study to evaluate the long‐term safety, tolerability and efficacy of Marstacimab prophylaxis in severe (coagulation factor activity <1%) hemophilia A participants with or without inhibitors or moderately severe to severe hemophilia B participants (coagulation factor Activity ≤2%) with or without inhibitors
Wali, Y.
٣/١/٢١ → …
المشروع: Other project